The story of the pharmaceutical company Moderna almost reads like a Hollywood screenplay. In its relatively short life, it has evolved from a scrappy start up to one of the hottest biotechs in the ...

Drug observers puzzled by vaccine maker, which made a killing on COVID-19, failing to read the room with new administration. Moderna puts heat on FDA vaccines chief who's already been rebuked once by ...

Moderna is a well-known biotech company from its pandemic success. Here's what investors should know about its growth story now.

Moderna (MRNA) stock has reached day 5 of a consecutive winning streak, with total gains during this time reaching a 13% return. The company’s value has increased by approximately $1.2 billion over ...

Moderna (MRNA) is scheduled to announce Q3 earnings results on November 6, before market open, with analysts’ consensus pointing to another quarter of losses. Citi expects Moderna to benefit from ...